HAART Use Improves Hepatitis B Vaccine Response, Even at High CD4 Counts (October 27, 2008)
HIV-positive patients are approximately twice as likely to respond to hepatitis B vaccination if they are receiving antiretroviral therapy, regardless of their CD4+ cell count at the time of vaccination, according to a study by researchers with the U.S. military. (An interview with Michael Landrum, M.D.)
In The 48th Annual ICAAC/IDSA 46th Annual Meeting, from TheBodyPRO
The Body is a service of Remedy Health Media, LLC, 750 3rd Avenue, 6th Floor, New York, NY 10017. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.